NCT00524199View on ClinicalTrials.gov

Effects of Mesna on Homocysteine in Kidney Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

June 30, 2007

Conditions
End Stage Renal Disease
Interventions
DRUG

Mesna

12 mg/kg IV infusion over five minutes at the beginning of dialysis thrice weekly.

OTHER

Saline

Saline IV infusion over five minutes at the beginning of dialysis thrice weekly.

Trial Locations (1)

N6A 5A5

London Health Sciences Centre, London

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00524199 - Effects of Mesna on Homocysteine in Kidney Failure | Biotech Hunter | Biotech Hunter